(Q74428457)

English

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group

scientific article published on 01 April 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

G C Farrell

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B R Bacon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R D Goldin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1121-1127

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term pathological evolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon for non-A, non-B chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term efficacy of interferon alfa in chronic hepatitis C patients: a critical review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of response to interferon treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predictive of the response to interferon in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomenclature of the human interferon proteins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of interferon-alpha 2 genes in humans.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270429

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510270429

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537453%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74428457&oldid=1749632124"